Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Patron in the transaction. Patron announced the formation of its Patron Fund II, a $100M seed-stage fund supporting...
Patron’s Closing of Fund iI at $100 Million
Orb’s $25 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Mayfield in the transaction. Orb, a billing software, announced raising $25 million in Series B financing led by...
TeamBridge’s $28 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Mayfield in the transaction. TeamBridge, the fastest-growing Workforce OS (workforce operating system) empowering hourly workforces, has raised $28...
Glean’s $260 Million Series E Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Altimeter, DST Global, Craft Ventures and Coatue, as investors in the transaction. Glean, an AI enterprise search startup,...
Finkargo’s $20 Million Equity Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Finkargo in the deal. Finkargo, a Latin American-based fintech, announced raising $20 million in equity financing led by...
Hims & Hers’ Acquisition of 503B Outsourcing Facility MedisourceRx
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Hims & Hers Health in the transaction. Hims & Hers Health, a multi-specialty telehealth platform, announced its acquisition...
Vignette Bio’s Merger with Candid Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction, and Cooley represented Candid Therapeutics. Candid Therapeutics, a biotechnology company, acquired Vignette Bio...
Brico’s $8.1 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brico in the transaction. Brico, a SaaS platform for managing fintech and financial institution licenses, raising $8.1 million...
Vignette Bio’s License Agreement with EpimAb Biotherapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction. Vignette Bio (“Vignette”) and EpimAb Biotherapeutics, Inc. (“EpimAB”) announced they have entered into...
Mintlify’s $18 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Mintlify in the transaction. Mintlify, a platform of documentation-authoring tools, announced raising $18 million in Series A financing...
Sakana AI’s $100 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented the lead investors in the transaction. Sakana AI, a Japan-based AI research and development company, announced raising $100...
ArsenalBio’s $325 Million Series C Financing Round
Cooley, Goodwin Procter and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Arsenal Biosciences on the transaction. Arsenal Biosciences (ArsenalBio) announced raising $325 million in Series...